In U251 cells, EGFRvIII expression inhibited TMZ-induced cell death by more than 45% (Figure 2E), consistent with the known feature of EGFR activation as an inducer of drug resistance in GBM (Oprita et al., 2021). The gene discussed is EGFR; the disease is glioblastoma.